HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Previous close
$0.66
Day range
$0.64 - $0.66
Year range
$0.41 - $0.78
Market cap
130.53M AUD
Avg Volume
212.02K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.19M | — |
Operating expense | 2.41M | -4.83% |
Net income | -3.73M | 19.09% |
Net profit margin | -313.34 | — |
Earnings per share | — | — |
EBITDA | -3.52M | 23.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.01M | 116.83% |
Total assets | 5.47M | 107.47% |
Total liabilities | 4.94M | 252.61% |
Total equity | 534.18K | — |
Shares outstanding | 203.70M | — |
Price to book | ∞ | — |
Return on assets | -165.04% | — |
Return on capital | -304.50% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.73M | 19.09% |
Cash from operations | -3.26M | 36.08% |
Cash from investing | -70.12K | -135.93% |
Cash from financing | 4.55M | 12,433.41% |
Net change in cash | 1.22M | 125.14% |
Free cash flow | -2.30M | 14.68% |
About
CEO
Founded
Apr 11, 2007
Website